Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Platelets|April 29, 2016
Clinical and laboratory characteristics in congenital ANKRD26 mutation-associated thrombocytopenia: A detailed phenotypic study of a familyJuliana Perez Botero, Dong Chen, Rong He, et al.
Synthetic and Systems Biotechnology|February 28, 2022
Engineering and characterization of dehalogenase enzymes from Delftia acidovorans in bioremediation of perfluorinated compoundsJackson D Harris, Collin M Coon, Megan E Doherty, et al.
American Journal of Hematology|May 24, 2018
Genotype-Phenotype Correlation of Hereditary Erythrocytosis Mutations, a single center experienceJennifer L Oliveira, Lea M Coon, Lori A Frederick, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|August 2, 2011
New Diversity Arrays Technology (DArT) markers for tetraploid oat (Avena magna Murphy et Terrell) provide the first complete oat linkage map and markers linked to domestication genes from hexaploid A. sativa LR E Oliver, E N Jellen, G Ladizinsky, et al.
American Journal of Medical Genetics. Part A|October 29, 2018
Severe bleeding with subclinical oculocutaneous albinism in a patient with a novel HPS6 missense variantChen G Han, Kevin J O'Brien, Lea M Coon, et al.
Cancers|June 2, 2021
Unmasking BCL-2 Addiction in Synovial Sarcoma by Overcoming Low NOXACarter K Fairchild, Konstantinos V Floros, Sheeba Jacob, et al.
Cancer Research|January 23, 2021
MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione AxisKonstantinos V Floros, JinYang Cai, Sheeba Jacob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2018
The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor ToxicityDaniel A R Heisey, Timothy L Lochmann, Konstantinos V Floros, et al.
Diseases (Basel, Switzerland)|December 23, 2017
Facilitating a More Efficient Commercial Review Process for Pediatric Drugs and BiologicsRyan D Rykhus, Zachary V Shepard, Alix Young, et al.
PNAS Nexus|January 30, 2023
Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer modelsSheeba Jacob, Tia H Turner, Jinyang Cai, et al.
Pageof 6